Metabolomics Workbench : NIH Data Repository

Reversed phase POSITIVE ION MODE (Analysis AN002036)

Metabolite	Structure	F1	F2	F3	F4
12-oxo-LTB4	ME290245	2.16	0.87	0.03	0.03
HETE	ME290247	1.91	1.15	0.02	0.04
PUFA	ME290243	2.00	1.08	0.01	0.01
Lyso-PAF C18	ME290233	1.61	1.12	0.29	0.36
Arachidonic acid	ME290246	1.41	1.46	0.18	0.28
PGB2	ME290244	1.59	1.44	0.07	0.10
Hexanoylcarnitine	ME290249	1.08	0.62	0.49	1.52
L-octanoylcarnitine	ME290236	1.15	0.58	0.42	1.51
Decanoylcarnitine	ME290248	1.22	0.65	0.39	1.34
L-acetylcarnitine	ME290235	1.17	0.70	0.50	1.31
Propionylcarnitine	ME290250	1.15	0.69	0.53	1.35
glycocholic acid	ME290226	1.68	0.70	0.35	0.71
glycochenodeoxycholic acid	ME290228	1.54	0.87	0.33	0.71
taurochenodeoxycholic acid	ME290231	1.55	0.72	0.38	0.85
taurodeoxycholic acid	ME290232	1.52	0.76	0.38	0.83
LysoPC (16:0)	ME290239	1.28	0.92	0.43	0.94
LysoPC (16:0) -2	ME290242	1.28	0.95	0.44	0.91
glycolithocholic acid	ME290230	1.15	0.98	0.49	1.03
glycoursodeoxycholic acid	ME290227	1.23	0.91	0.48	1.02
LysoPC (20:0)	ME290237	1.39	1.09	0.35	0.65
LysoPC (20:0) -2	ME290240	1.38	1.11	0.38	0.63
SM (d18:1/16:0)	ME290234	1.36	1.02	0.42	0.74
LysoPC (18:0)	ME290238	1.34	0.96	0.40	0.83
LysoPC (18:0) -2	ME290241	1.35	1.01	0.36	0.79
glycodeoxycholic acid	ME290229	1.41	0.91	0.44	0.79
Sphingosine (d16:0)	ME290251	1.47	0.91	0.44	0.71

F1	Sample Type:Early Disseminated Lyme
F2	Sample Type:Early Localized Lyme
F3	Sample Type:Healthy Non-endemic control
F4	Sample Type:Heatlhy Controls - Endemic

Data matrix